These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 26826411)

  • 21. Decreased ARID1A expression correlates with poor prognosis of clear cell renal cell carcinoma.
    Park JH; Lee C; Suh JH; Chae JY; Kim HW; Moon KC
    Hum Pathol; 2015 Mar; 46(3):454-60. PubMed ID: 25628030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An Integrative Morphomolecular Classification System of Gastric Carcinoma With Distinct Clinical Outcomes.
    Tsai JH; Jeng YM; Chen KH; Lee CH; Yuan CT; Liau JY
    Am J Surg Pathol; 2020 Aug; 44(8):1017-1030. PubMed ID: 32568823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High expression of CD11c indicates favorable prognosis in patients with gastric cancer.
    Wang Y; Xu B; Hu WW; Chen LJ; Wu CP; Lu BF; Shen YP; Jiang JT
    World J Gastroenterol; 2015 Aug; 21(31):9403-12. PubMed ID: 26309367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intratumoral heterogeneity and loss of ARID1A expression in gastric cancer correlates with increased PD-L1 expression in Western patients.
    Tober JM; Halske C; Behrens HM; Krüger S; Röcken C
    Hum Pathol; 2019 Dec; 94():98-109. PubMed ID: 31704366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of FOXO3a suggests good prognosis of patients with radically resected gastric cancer.
    Yu S; Yu Y; Sun Y; Wang X; Luo R; Zhao N; Zhang W; Li Q; Cui Y; Wang Y; Li W; Liu T
    Int J Clin Exp Pathol; 2015; 8(3):2963-70. PubMed ID: 26045805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemistry as a surrogate for molecular subtyping of gastric adenocarcinoma.
    Gonzalez RS; Messing S; Tu X; McMahon LA; Whitney-Miller CL
    Hum Pathol; 2016 Oct; 56():16-21. PubMed ID: 27342907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Morphological Features and Prognostic Significance of ARID1A-Deficient Esophageal Adenocarcinomas.
    Drage MG; Tippayawong M; Agoston AT; Zheng Y; Bueno R; Hornick JL; Odze RD; Srivastava A
    Arch Pathol Lab Med; 2017 Jul; 141(7):970-977. PubMed ID: 28440661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of Hes1 expression is associated with poor prognosis in colorectal adenocarcinoma.
    Ahadi M; Andrici J; Sioson L; Sheen A; Clarkson A; Gill AJ
    Hum Pathol; 2016 Nov; 57():91-97. PubMed ID: 27476040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High Ki67 Expression has Prognostic Value in Surgically-Resected T3 Gastric Adenocarcinoma.
    Huang G; Chen S; Wang D; Wang R; Lin L; Chen S; Wang L; Huang Q
    Clin Lab; 2016; 62(1-2):141-53. PubMed ID: 27012044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased expression of pleiotrophin is a prognostic marker for patients with gastric cancer.
    Hu H; Li C; Cai S; Zhu C; Tian Y; Zheng J; Hu J; Chen C; Liu W
    Hepatogastroenterology; 2014; 61(133):1478-82. PubMed ID: 25436328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinicopathological significance of SIRT1 and p300/CBP expression in gastroesophageal junction (GEJ) cancer and the correlation with E-cadherin and MLH1.
    Zhang LH; Huang Q; Fan XS; Wu HY; Yang J; Feng AN
    Pathol Res Pract; 2013 Oct; 209(10):611-7. PubMed ID: 24035280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicopathological significance of cathepsin D expression in gastric adenocarcinoma.
    Ikeguchi M; Fukuda K; Oka S; Yamaguchi K; Hisamitsu K; Tsujitani S; Sakatani T; Ueda T; Kaibara N
    Oncology; 2001; 61(1):71-8. PubMed ID: 11474252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. STAT3 expression in gastric cancer indicates a poor prognosis.
    Kim DY; Cha ST; Ahn DH; Kang HY; Kwon CI; Ko KH; Hwang SG; Park PW; Rim KS; Hong SP
    J Gastroenterol Hepatol; 2009 Apr; 24(4):646-51. PubMed ID: 19175826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Absolute monocyte and lymphocyte count prognostic score for patients with gastric cancer.
    Eo WK; Jeong DW; Chang HJ; Won KY; Choi SI; Kim SH; Chun SW; Oh YL; Lee TH; Kim YO; Kim KH; Ji YI; Kim A; Kim HY
    World J Gastroenterol; 2015 Mar; 21(9):2668-76. PubMed ID: 25759535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer.
    Sun XR; Sun Z; Zhu Z; Guan HX; Li CY; Zhang JY; Zhang YN; Zhou H; Zhang HJ; Xu HM; Sun MJ
    World J Gastroenterol; 2015 May; 21(17):5336-44. PubMed ID: 25954108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DOK2 as a marker of poor prognosis of patients with gastric adenocarcinoma after curative resection.
    Miyagaki H; Yamasaki M; Takahashi T; Kurokawa Y; Miyata H; Nakajima K; Takiguchi S; Fujiwara Y; Mori M; Doki Y
    Ann Surg Oncol; 2012 May; 19(5):1560-7. PubMed ID: 22130622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Smad4 loss in esophageal adenocarcinoma is associated with an increased propensity for disease recurrence and poor survival.
    Singhi AD; Foxwell TJ; Nason K; Cressman KL; McGrath KM; Sun W; Bahary N; Zeh HJ; Levy RM; Luketich JD; Davison JM
    Am J Surg Pathol; 2015 Apr; 39(4):487-95. PubMed ID: 25634752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of ACSS2 expression predicts poor prognosis in patients with gastric cancer.
    Hur H; Kim YB; Ham IH; Lee D
    J Surg Oncol; 2015 Nov; 112(6):585-91. PubMed ID: 26381042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nuclear overexpression of the overexpressed in lung cancer 1 predicts worse prognosis in gastric adenocarcinoma.
    Wang J; Shen H; Fu G; Zhao D; Wang W
    Oncotarget; 2017 Feb; 8(6):9442-9450. PubMed ID: 28038462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diagnostic and prognostic values of repair protein hMLH1, hMSH2 and protein CD34 immunoexpression in sporadic colorectal cancer].
    Słomka M; Stasikowska O; Wagrowska-Danilewicz M; Danilewicz M; Małecka-Panas E
    Pol Merkur Lekarski; 2010 Dec; 29(174):351-6. PubMed ID: 21298983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.